30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Avalon BioVentures SPV I, L.P.

Track

Insider profile

Avalon BioVentures SPV I, L.P.'s trades of Janux Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-01 2024-11-01
PrS Proposed sale
521
260.02
US$473,712 		521 260.02 US$473,712
2024-10-25 2024-10-25
PrS Proposed sale
40,422
73.75
US$2,231,262 		40,422 73.75 US$2,231,262
2024-10-23 2024-10-23
PrS Proposed sale
76,129
334.70
US$2,373,794 		76,129 334.70 US$2,373,794
2024-10-18 2024-10-18
PrS Proposed sale
120,680
50.38
US$6,079,984 		120,680 50.38 US$6,079,984
2024-10-16 2024-10-16
PrS Proposed sale
91,539
49.96
US$4,572,999 		91,539 49.96 US$4,572,999
2024-09-27 2024-09-27
PrS Proposed sale
48,403
46.43
US$2,247,248 		48,403 46.43 US$2,247,248
2024-09-26 2024-09-26
PrS Proposed sale
92,200
47.19
US$4,350,513 		92,200 47.19 US$4,350,513
2024-09-12 2024-09-12
PrS Proposed sale
161,356
47.00
US$7,583,732 		161,356 47.00 US$7,583,732
2024-09-10 2024-09-10
PrS Proposed sale
46,604
45.52
US$2,121,414 		46,604 45.52 US$2,121,414
2024-09-06 2024-09-06
PrS Proposed sale
110,644
41.26
US$4,565,171 		110,644 41.26 US$4,565,171
2024-06-03 2024-06-03
PrS Proposed sale
691,525
54.96
US$38,006,214 		691,525 54.96 US$38,006,214